相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SynPathy: Predicting Drug Synergy through Drug-Associated Pathways Using Deep Learning
Yi-Ching Tang et al.
MOLECULAR CANCER RESEARCH (2022)
Anticancer drug synergy prediction in understudied tissues using transfer learning
Yejin Kim et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2021)
IL-12 Family Cytokines in Cancer and Immunotherapy
Bhalchandra Mirlekar et al.
CANCERS (2021)
Intratumoral Plasmid IL12 Expands CD8+ T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti-PD-1 Therapy
Melinda L. Telli et al.
CLINICAL CANCER RESEARCH (2021)
Explainable drug sensitivity prediction through cancer pathway enrichment
Yi-Ching Tang et al.
SCIENTIFIC REPORTS (2021)
Facilitating Drug Discovery in Breast Cancer by Virtually Screening Patients Using In Vitro Drug Response Modeling
Robert F. Gruener et al.
CANCERS (2021)
Synthetic lethality-mediated precision oncology via the tumor transcriptome
Joo Sang Lee et al.
CELL (2021)
mTOR controls endoplasmic reticulum-Golgi apparatus trafficking of VSVg in specific cell types
Alicja Koscielny et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2021)
Tumour-targeted interleukin-12 and entinostat combination therapy improves cancer survival by reprogramming the tumour immune cell landscape
Kristin C. Hicks et al.
NATURE COMMUNICATIONS (2021)
Tumor-associated macrophages are associated with response to neoadjuvant chemotherapy and poor outcomes in patients with triple-negative breast cancer
Jia-hui Ye et al.
JOURNAL OF CANCER (2021)
Vesicular trafficking-related proteins as the potential therapeutic target for breast cancer
Mohd Mughees et al.
PROTOPLASMA (2020)
TP53 Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial
Marianne Sinn et al.
CLINICAL CANCER RESEARCH (2020)
Computational Cancer Cell Models to Guide Precision Breast Cancer Medicine
Lijun Cheng et al.
GENES (2020)
Pharmacologic profiling of patient-derived xenograft models of primary treatment-naive triple-negative breast cancer
Reid T. Powell et al.
SCIENTIFIC REPORTS (2020)
Emerging role of mTOR in tumor immune contexture: Impact on chemokine-related immune cells migration
Jing Jin et al.
THERANOSTICS (2020)
MOLI: multi-omics late integration with deep neural networks for drug response prediction
Hossein Sharifi-Noghabi et al.
BIOINFORMATICS (2019)
Expression Levels of Therapeutic Targets as Indicators of Sensitivity to Targeted Therapeutics
Riti Roy et al.
MOLECULAR CANCER THERAPEUTICS (2019)
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2019)
Tumor cell expression of CD163 is associated to postoperative radiotherapy and poor prognosis in patients with breast cancer treated with breast-conserving surgery
Stina Garvin et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
A transfer learning approach via procrustes analysis and mean shift for cancer drug sensitivity prediction
Turki Turki et al.
JOURNAL OF BIOINFORMATICS AND COMPUTATIONAL BIOLOGY (2018)
Application of transfer learning for cancer drug sensitivity prediction
Saugato Rahman Dhruba et al.
BMC BIOINFORMATICS (2018)
HDAC inhibition potentiates immunotherapy in triple negative breast cancer
Manuela Terranova-Barberio et al.
ONCOTARGET (2017)
Evaluating the molecule-based prediction of clinical drug responses in cancer
Zijian Ding et al.
BIOINFORMATICS (2016)
A Landscape of Pharmacogenomic Interactions in Cancer
Francesco Iorio et al.
CELL (2016)
The Role of Cytokines in Breast Cancer Development and Progression
Marcela Esquivel-Velazquez et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
Hui Gao et al.
NATURE MEDICINE (2015)
Cancer Cell Lines for Drug Discovery and Development
Jennifer L. Wilding et al.
CANCER RESEARCH (2014)
Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines
Paul Geeleher et al.
GENOME BIOLOGY (2014)
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
Wanjuan Yang et al.
NUCLEIC ACIDS RESEARCH (2013)
Role of interleukin-10 in breast cancer
Hamidullah et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Molecular signatures database (MSigDB) 3.0
Arthur Liberzon et al.
BIOINFORMATICS (2011)
Histone deacetylases and the immunological network: implications in cancer and inflammation
A. Villagra et al.
ONCOGENE (2010)
PID: the Pathway Interaction Database
Carl F. Schaefer et al.
NUCLEIC ACIDS RESEARCH (2009)
Specific Activity of Class II Histone Deacetylases in Human Breast Cancer Cells
Vanessa Duong et al.
MOLECULAR CANCER RESEARCH (2008)
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements
Leming Shi et al.
NATURE BIOTECHNOLOGY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
分享论文
